Drug intelligence / Profile preview

algidol

Development stage
Unknown
Modality
Small Molecules, Drug Delivery Systems
Administration
Oral, Intramuscular
01

Overview

Algidol is a combination analgesic and antipyretic medication available in several countries, most notably Spain and some Latin American markets. Its formulation varies by country, but the most common version contains paracetamol (acetaminophen), codeine phosphate, and ascorbic acid (vitamin C). In some regions, formulations may also include ibuprofen or acetylsalicylic acid (aspirin). The primary mechanism of action involves pain relief through central inhibition of prostaglandin synthesis by paracetamol, opioid receptor agonism by codeine after hepatic conversion to morphine, and antioxidant effects from ascorbic acid. It is indicated for symptomatic treatment of moderate pain and febrile states[1][2][5][7].

Brand names
Algidol
02

Targets

MOR (Mu opioid receptor)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on algidol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on algidol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call